StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / myricxbio.com

Myricx Bio

Myricx Bio (myricxbio.com): no confident changes recorded yet; website history since September 2023. Homepage last checked 6 November 2026.

First recorded website

Observed 22 September 2023

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Developing a new class of ADCs based on NMT inhibition to treat cancer

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. September 2023 – November 2026 · 7 captures · latest observed messagingDeveloping the first class of ADCs based on NMT inhibition to treat cancer

    This wording observed 6 November 2026.

    Inspect 7 captures in this group
    • 22 September 2023 · Developing a new class of ADCs based on NMT inhibition to treat cancer archived page
    • 5 February 2024 · Developing the first class of ADCs based on NMT inhibition to treat cancer archived page
    • 8 July 2024 · Developing the first class of ADCs based on NMT inhibition to treat cancer archived page
    • 6 January 2025 · Developing the first class of ADCs based on NMT inhibition to treat cancer archived page
    • 23 September 2025 · Developing the first class of ADCs based on NMT inhibition to treat cancer archived page
    • 6 July 2026 · Developing the first class of ADCs based on NMT inhibition to treat cancer archived page
    • 6 November 2026 · Developing the first class of ADCs based on NMT inhibition to treat cancer current websiteHistorical capture not publicly available

Cite this record

StartupHistory, “Myricx Bio” company record, https://startuphistory.org/c/myricxbio.com

Machine-readable: /c/myricxbio.com.json. How changes are found: method.